about
Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for SchizophreniaVasorelaxing Action of the Kynurenine Metabolite, Xanthurenic Acid: The Missing Link in Endotoxin-Induced Hypotension?Altered serum levels of kynurenine metabolites in patients affected by cluster headacheAltered kynurenine pathway metabolites in serum of chronic migraine patientsFathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important.Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors.N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors.Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1.Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation.Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis.Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in SchizophreniaTargeting metabotropic glutamate receptors for the treatment of neuroinflammationSerum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis
P50
Q28270694-396425EE-E3D1-4909-98ED-B68C4FF8397CQ33619271-0DF5461C-D5EB-4668-80B7-148527FB0CD1Q36712255-6BD94FB2-9579-4D9D-9940-7777DE07A4C6Q36853404-917CF4EE-0A60-4E50-B538-443273697722Q38364549-666D7C15-30F7-4A82-8375-206CF2EC5C8FQ38876214-D79D71C7-0B32-421F-8183-8409BE63D84CQ41843975-04FE8259-494B-401A-AA73-1F024A40C822Q42264500-78CD608D-DD63-437B-995B-A5AE268C788FQ42958588-D5869EF0-905B-4682-86DF-B878CA723266Q43782014-B5E29E8E-D7E4-4D97-A026-B1328B5121D1Q46488583-3DFF24B5-4FE5-4061-A085-DD5C1BC983B3Q64261706-05C29131-FFF9-4F8D-BD5B-30C62D73FE9BQ87851428-2074B6C7-F3DD-4591-BDAF-9199ACC475C5Q92147529-DE2CBEF5-9B35-462C-96B5-C8EF7A0027A6
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2662-1588
@en
name
F Fazio
@ast
F Fazio
@en
F Fazio
@es
F Fazio
@nl
type
label
F Fazio
@ast
F Fazio
@en
F Fazio
@es
F Fazio
@nl
prefLabel
F Fazio
@ast
F Fazio
@en
F Fazio
@es
F Fazio
@nl
P106
P1153
24486854000
P31
P496
0000-0003-2662-1588